6-Nitro-4H-benzo[d][1,3]thiazin-2-amine
Abstract
:1. Introduction
2. Experimental
6-Nitro-4H-benzo[d][1,3]thiazin-2-amine (1)
Supplementary Materials
Supplementary File 1Supplementary File 2Supplementary File 3Supplementary File 4Acknowledgments
Author Contributions
Conflicts of Interest
References and Notes
- Compound 2 is prepared in three steps from commercial 2-fluorobenzaldehyde by nitration (NaNO2 in H2SO4), aldehyde reduction (BH3·THF in THF or NaBH4 in EtOH), and conversion to the bromide (PBr3 in Et2O), see Bunce, R.A.; Rogers, D.; Nago, T.; Bryant, S.A. 4H-1-Benzopyrans by a tandem SN2-SNAr reaction. J. Heterocycl. Chem. 2008, 45, 547–550. [Google Scholar] [CrossRef] Compound 2 is also commercially available from Oakwood Products. Inc. [1-(800)-467-3386. Available online: www.oakwoodchemical.com (accessed on 9 May 2016).], though it is rather expensive.
- Bunce, R.A.; Nago, T.; Sonobe, N.; Slaughter, L.M. Benzo-fused heterocycles and carbocycles by intramolecular SNAr and tandem SN2-SNAr reactions. J. Heterocycl. Chem. 2008, 45, 551–557. [Google Scholar] [CrossRef]
- Hall, A.; Farthing, C.N.; Pineiro, J.L.C. Preparation of Fused Aminodihydrothiazine Derivs. Useful as BACE Inhibitors and Amyloid β Inhibitors for Treating Neurodegenerative Disease. World Patent WO 2012098213 A1, 2012. Chem. Abstr. 2012, 157, 261855. [Google Scholar]
- Brodney, M.A.; Butler, C.R.; Helal, C.J.; O'Neill, B.T. Preparation of Hexahydro-pyrano[3,4-d][1,3]thiazin-2-amine Derivatives as BACE Inhibitors Useful in the Treatment of Neurodegenerative Disease. U.S. Patent US20130053373 A1, 2013. Chem. Abstr. 2013, 158, 390009. [Google Scholar]
- Beck, E.M.; Brodney, M.A.; Butler, C.R.; Davoren, J.E.; O'Neill, B.T. Heterocyclic Substituted Hexahydropyrano[3,4-d][1,3]thiazin-2-amine Compounds as Inhibitors of APP, BACE1 and BACE2 and Their Preparation. World Patent WO 2013164730 A1, 2013. Chem. Abstr. 2013, 159, 714182. [Google Scholar]
- Hall, A.; Farthing, C.N.; Eatherton, A.J. Hexahydropyrrolothiazine Compounds as BACE1 Inhibitors and Their Preparation. World Patent WO 2014013076 A1, 2014. Chem. Abstr. 2014, 160, 219225. [Google Scholar]
- Hall, A.; O'Connor, D.M. Preparation of Furo[3,4-d][1,3]thiazinyl Compounds as BACE1 Inhibitors for Treating Neurodegenerative Diseases. British Patent GB 2504615 A1, 2014. Chem. Abstr. 2014, 160, 265100. [Google Scholar]
- Beck, E.M.; Brodney, M.A.; Butler, C.R.; Davoren, J.E. Preparation of Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine Compounds as BACE1 and BACE2 Inhibitors. World Patent WO 2014045162 A1, 2014. Chem. Abstr. 2014, 160, 515614. [Google Scholar]
- Brodney, M.A.; Beck, E.M.; Butler, C.R.; Davoren, J.E.; O'Neill, B.T. Preparation of Hexahydro-pyrano[3,4-d][1,3]thiazin-2-amine Compounds as BACE1 Inhibitors for Treating Neurological Disorders, Diabetes and Obesity. U.S. Patent US 20140163015 A1, 2014. Chem. Abstr. 2014, 161, 99258. [Google Scholar]
- Brodney, M.A.; Butler, C.R.; Lachapelle, E.A.; O'Neill, B.T. Preparation of Hexahydropyrano[3,4-d][1,3]thiazin-2-amine Compounds as BACE Inhibitors for Treatment of Alzheimers Disease and Other Disorders. World Patent WO 2014097038 A1, 2014. Chem. Abstr. 2014, 161, 171688. [Google Scholar]
- Brodney, M.A.; Butler, C.R.; Beck, E.M.; Davoren, J.E.; LaChapelle, E.A.; O'Neill, B.T. Preparation of Heteroaryl-substituted Hexahydropyrano[3,4-d][1,3]thiazin-2-amine Compounds. U.S. Patent US 20140228356 A1, 2014. Chem. Abstr. 2014, 161, 336389. [Google Scholar]
- Beck, E.M.; Brodney, M.A.; Butler, C.R.; O'Neill, B.T. Preparation of Substituted Phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine Compounds Useful in the Treatment of Neurodegenerative Diseases and Diabetes. World Patent WO 2014125397 A1, 2014. Chem. Abstr. 2014, 161, 390000. [Google Scholar]
- Pineiro, J.L.C.; Guerot, C. Preparation of 4a,6,7,7a-Tetrahydro-4H-furo[3,2-d][1,3]thiazin-2-amine Derivatives for the Treatment of Alzheimer-Type Dementia. British Patent GB 2512975 A1, 2014. Chem. Abstr. 2014, 161, 613558. [Google Scholar]
- Brodney, M.A.; Beck, E.M.; Butler, C.R.; Zhang, L.; O'Neill, B.T.; Barreiro, G.; Lachapelle, E.A.; Rogers, B.N. Preparation of N-(2-Amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl) amides as Inhibitors of beta-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1). World Patent WO 2015155626 A1, 2015. Chem. Abstr. 2015, 163, 585749. [Google Scholar]
- Thanusu, J.; Kanagarajan, V.; Gopalakrishnan, M. Synthesis, spectral characterization, and in vitro antibacterial and antifungal activities of novel 1,3-thiazine-2-amines comprising morpholine nucleus. J. Enzyme Inhib. Med. Chem. 2010, 25, 756–764. [Google Scholar] [CrossRef] [PubMed]
- Kanagarajan, V.; Gopalakrishnan, M. Domino way toward the synthesis of novel 4-(4-morpholinophenyl)-6-aryl-6H-1,3-thiazin-2-amines under focused microwave irradiation catalyzed by heterogeneous NaHSO4·SiO2 and their in vitro microbiological evaluation. Pharm. Chem. J. 2011, 45, 248–256. [Google Scholar] [CrossRef]
- Wu, Y.-J.; Guernon, J.; Park, H.; Thompson, L.A. Expedient synthesis of furo[2,3-d][1,3]-thiazinamines and pyrano[2,3-d][1,3]thiazinamines from enones and thiourea. J. Org. Chem. 2016, 81, 3386–3390. [Google Scholar] [CrossRef] [PubMed]
- Pandey, G.; Bhowmik, S.; Batra, S. Synthesis of 4-substituted imino-4H-benzo[d][1,3] thiazin-2-amines via palladium-catalysed isocyanide insertion in 2-bromophenylthioureas. RSC Adv. 2014, 4, 41433–41436, and references cited therein. [Google Scholar] [CrossRef]
- Kong, K.H.; Tan, C. K.; Lin, X.; Lam, Y. A versatile thiouronium-based solid-phase synthesis of 1,3,5-triazines. Chem. Eur. J. 2012, 18, 1476–1486. [Google Scholar] [CrossRef] [PubMed]
- The intermediate isothiouronium bromide salt was isolated when the first stage of the reaction was performed in anhydrous acetonitrile (room temperature, 24 h, 92%). The spectral data were: IR (nujol): 3302, 3274, 3187, 1656, 1521, 1346 cm−1; 1H NMR (400 MHz, DMSO-d6): δ 9.28 (br s, 4H), 8.52 (dd, J = 6.4, 3.0 Hz, 1H), 8.31 (ddd, J = 9.1, 4.3, 3.0 Hz, 1H), 7.60 (t, J = 9.2 Hz, 1H), 4.70 (s, 2H); 13C NMR (100 MHz, DMSO-d6): δ 168.6, 165.7, 163.1, 144.3, 127.20, 127.15, 126.9, 126.8, 125.3, 125.1, 118.0, 28.4.
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gnanasekaran, K.K.; Hiett, J.T.; Bunce, R.A. 6-Nitro-4H-benzo[d][1,3]thiazin-2-amine. Molbank 2016, 2016, M899. https://doi.org/10.3390/M899
Gnanasekaran KK, Hiett JT, Bunce RA. 6-Nitro-4H-benzo[d][1,3]thiazin-2-amine. Molbank. 2016; 2016(2):M899. https://doi.org/10.3390/M899
Chicago/Turabian StyleGnanasekaran, Krishna Kumar, John T. Hiett, and Richard A. Bunce. 2016. "6-Nitro-4H-benzo[d][1,3]thiazin-2-amine" Molbank 2016, no. 2: M899. https://doi.org/10.3390/M899
APA StyleGnanasekaran, K. K., Hiett, J. T., & Bunce, R. A. (2016). 6-Nitro-4H-benzo[d][1,3]thiazin-2-amine. Molbank, 2016(2), M899. https://doi.org/10.3390/M899